A Case-Control Study of the Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma in Australia

Objective. We investigate the prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma (OSCC) tissues compared to oesophageal tissue from healthy controls, in an Australian cohort. Methods. We conducted a hospital-based case-control study of 99 patients with OSCC and 100 healthy controls to examine the presence of HPV DNA. Paraffin tissues were tested using the PapType high-risk HPV detection and genotyping kit and with INNO-LiPA HPV Genotyping Extra. The biopsy samples were tested for HPV using a PCR-ELISA method based on the L1 consensus primer set PGMY09-PGMY11. Results. HPV DNA of the oncogenic genotype 16 was detected in 1/99 case specimens, a rate of 1010 per 100,000 (95% CI: 30–5500). All control specimens were negative for HPV. Significantly higher rates of smoking, other aerodigestive cancers, and mortality were seen among cases than controls. A pooled analysis of this study and the only other Australian case-control study found that 9/321 cases and 0/155 controls were positive for HPV. The pooled odds ratio for HPV being a risk factor for OSCC was 9.35 (95% CI: 0.47–190.33). Conclusion. Our results suggest that in this multifactorial cancer HPV may be an additional risk factor; although a larger, better powered study is needed.

[1]  S. Garland,et al.  The Aetiological Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma: A Meta-Analysis , 2013, PloS one.

[2]  S. Garland,et al.  Role of human papillomaviruses in esophageal squamous cell carcinoma , 2013, Asia-Pacific journal of clinical oncology.

[3]  Anna Trakoli IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. International Agency for Research on Cancer , 2012 .

[4]  S. Garland,et al.  Comparison of the INNO-LiPA and PapType Assays for Detection of Human Papillomavirus in Archival Vulva Dysplasia and/or Neoplasia Tissue Biopsy Specimens , 2011, Journal of Clinical Microbiology.

[5]  S. Garland,et al.  High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma—Letter , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[6]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[7]  N. Hayward,et al.  High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[8]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[9]  S. Garland,et al.  Human Papillomavirus Genotyping Using Archival Vulval Dysplastic or Neoplastic Biopsy Tissues: Comparison between the INNO-LiPA and Linear Array Assays , 2010, Journal of Clinical Microbiology.

[10]  Paolo Boffetta,et al.  High‐temperature beverages and foods and esophageal cancer risk—A systematic review , 2009, International journal of cancer.

[11]  G. Enders,et al.  LINEAR ARRAY Human Papillomavirus Genotyping Test Amenable to Automation by Implementation of GT-Blot 48 – A Pilot Study , 2008 .

[12]  S. Garland,et al.  Validation of an Automated Detection Platform for Use with the Roche Linear Array Human Papillomavirus Genotyping Test , 2008, Journal of Clinical Microbiology.

[13]  W. Melchers,et al.  Evaluation of the SPF10-INNO LiPA Human Papillomavirus (HPV) Genotyping Test and the Roche Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.

[14]  S. Garland,et al.  Human papillomavirus genotyping using a modified linear array detection protocol. , 2006, Journal of virological methods.

[15]  Y. Ke,et al.  LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. , 2005, Carcinogenesis.

[16]  S. Garland,et al.  Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus. , 2005, American journal of clinical pathology.

[17]  H. Stein,et al.  Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences , 2004, International journal of cancer.

[18]  M. Blaser,et al.  Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[19]  K. Syrjänen,et al.  HPV infections and oesophageal cancer , 2002, Journal of clinical pathology.

[20]  S. Merluzzi,et al.  Detection of Human Papillomavirus DNA and p53 Gene Mutations in Esophageal Cancer Samples and Adjacent Normal Mucosa , 2001, Digestion.

[21]  C. la Vecchia,et al.  Food groups and risk of squamous cell esophageal cancer in Northern Italy , 2000, International journal of cancer.

[22]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[23]  Paul D. Allison,et al.  Logistic Regression Using the SAS System : Theory and Application , 1999 .

[24]  G. Launoy,et al.  Diet and squamous‐cell cancer of the oesophagus: A French multicentre case‐control study , 1998, International journal of cancer.

[25]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[26]  J. Icenogle,et al.  Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska natives , 1997, International journal of cancer.

[27]  S. Garland,et al.  Cervical adenoid basal carcinoma, five cases and literature review , 1996 .

[28]  M. Cravo,et al.  High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction , 1995, Cancer.

[29]  Jerzy K. Kulski,et al.  Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. , 1990, American journal of clinical pathology.

[30]  Jerzy K. Kulski,et al.  HUMAN PAPILLOMA VIRUS DNA IN OESOPHAGEAL CARCINOMA , 1986, The Lancet.

[31]  J. Hille,et al.  Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[32]  K. Syrjänen,et al.  Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). , 1982, Diagnostic histopathology.

[33]  H. Hashemian,et al.  [Esophageal cancer in Iran]. , 1965, Journal de radiologie, d'electrologie, et de medecine nucleaire.

[34]  W. Marsden I and J , 2012 .

[35]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[36]  Jin-Yong Kang,et al.  Epidemiology and Clinical Presentation in Esophageal Cancer , 2008 .

[37]  R. Holmes,et al.  Epidemiology and pathogenesis of esophageal cancer. , 2007, Seminars in radiation oncology.

[38]  M. Campo,et al.  HPV and oesophageal carcinoma. , 2006 .

[39]  K. Sugimachi,et al.  Papillomavirus and esophageal cancer in the Japanese and Chinese. , 1989, American Journal of Gastroenterology.

[40]  E. Somers International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.